A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems

Virology

Volumn 272, Issue 2, 2000, Pages 315-325

  Adam, J L ^a   Briggs, M W ^a   McCance, D J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CELL VACUOLE; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVITY; GENE EXPRESSION SYSTEM; HYDROPHOBICITY; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; WART VIRUS; YEAST;

EID: 0034608898     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0376     Document Type: Article

References (55)

1. Andresson T., Sparkowski J., Goldstein D. J., Schlegel R. Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J. Biol. Chem. 270:1995;6830-6837.
2. Ashrafi G. H., Pitts J. D., Faccini A., McLean P., O'Brien V., Finbow M. E., Campo M. S. Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events. J. Gen. Virol. 81:2000;689-694.
3. Briggs, M. W, and, McCance, D. J. A Saccharomyces cerevisiae model system for the study of HPV-16 E5 function: Interactions between the E5 protein, the vacuolar H(+)-ATPase and the molecular chaperone Jem1p. Submitted for publication.
4. Broach J. R., Li Y.-Y., Wu L.-C. C., Jayaram M. Vectors for high-level, inducible expression of cloned genes in yeast. Experimental Manipulation of Gene Expression. 1983;Academic Press, San Diego. p. 83-117.
5. Bubb V., McCance D. J., Schlegel R. DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. Virology. 163:1988;243-246.
6. Burkhardt A., Willingham M., Gay C., Jeang K. T., Schlegel R. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology. 170:1989;334-339.
7. Cohen B. D., Goldstein D. J., Rutledge L., Vass W. C., Lowry D. R., Schlegel R., Schiller J. T. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J. Virol. 67:1993;5303-5311.
8. Conrad M., Bubb V. J., Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:1993;6170-6178.
9. Conrad M., Goldstein D., Andresson T., Schlegel R. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology. 200:1994;796-800.
10. Crusius K., Auvinen E., Alonso A. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene. 15:1997;1437-1444.
11. Crusius K., Auvinen E., Steuer B., Gaissert H., Alonso A. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. Exp. Cell Res. 241:1998;76-83.
12. DiMaio D., Guralski D., Schiller J. T. Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity. Proc. Natl. Acad. Sci. USA. 83:1986;1797-1801.
13. Doherty R. D., Kane P. M. Partial assembly of the yeast vacuolar H(+)-ATPase in mutants lacking one subunit of the enzyme. J. Biol. Chem. 268:1993;16845-16851.
14. Dyson N., Howley P. M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
15. Faccini A. M., Cairney M., Ashrafi G. H., Finbow M. E., Campo M. S., Pitts J. D. The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J. Virol. 70:1996;9041-9045.
16. Foury F. The 31-kDa polypeptide is an essential subunit of the vacuolar ATPase in Saccharomyces cerevisiae. J. Biol. Chem. 265:1990;18554-18560.
17. + ATPase. J. Virol. 67:1993;7701-7704.
18. Goldstein D. J., Andresson T., Sparkowski J. J., Schlegel R. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J. 11:1992a;4851-4859.
19. Goldstein D. J., Finbow M. E., Andresson T., McLean P., Smith K., Bubb V., Schlegel R. Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases. Nature. 352:1991;347-349.
20. Goldstein D. J., Kulke R., Dimaio D., Schlegel R. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase. J. Virol. 66:1992b;405-413.
21. Goldstein D. J., Toyama R., Dhar R., Schlegel R. The BPV-1 E5 oncoprotein expressed in Schizosaccharomyces pombe exhibits normal biochemical properties and binds to the endogenous 16-kDa component of the vacuolar proton-ATPase. Virology. 190:1992c;889-893.
22. Gu Z., Matlashewski G. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. J. Virol. 69:1995;8051-8056.
23. Halbert C. L., Galloway D. A. Identification of the E5 open reading frame of human papillomavirus type 16. J. Virol. 62:1988;1071-1075.
24. Higuchi R., Krummel B., Saiki R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucleic Acids Res. 16:1988;7351-7367.
25. Horwitz B. H., Weinstat D. L., DiMaio D. Transforming activity of a 16-amino-acid segment of the bovine papillomavirus E5 protein linked to random sequences of hydrophobic amino acids. J. Virol. 63:1989;4515-4519.
26. Hwang E. S., Nottoli T., Dimaio D. The HPV16 E5 protein: Expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology. 211:1995;227-233.
27. Jones J. S., Prakash L. Yeast Saccharomyces cerevisiae selectable markers in pUC18 polylinkers. Yeast. 6:1990;363-366.
28. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 44:1986;283-292.
29. Kulke R., Horwitz B. H., Zibello T., DiMaio D. The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many hydrophobic amino acid sequences containing a glutamine. J. Virol. 66:1992;505-511.
30. Leechanachai P., Banks L., Moreau F., Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene. 7:1992;19-25.
31. McCance D. J., Campion M. J., Clarkson P. K., Chesters P. M., Jenkins D., Singer A. Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br. J. Obstetr. Gynaecol. 92:1985;1101-1105.
32. Munger K., Werness B. A., Dyson N., Phelps W. C., Harlow E., Howley P. M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:1989;4099-4105.
33. Noumi T., Beltran C., Nelson H., Nelson N. Mutational analysis of yeast vacuolar H(+)-ATPase. Proc. Natl. Acad. Sci. USA. 88:1991;1938-1942.
34. Oelze I., Kartenbeck J., Crusius K., Alonso A. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69:1995;4489-4494.
35. Petti L., DiMaio D. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. Proc. Natl. Acad. Sci. USA. 89:1992;6736-6740.
36. Petti L., Nilson L. A., DiMaio D. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10:1991;845-855.
37. Pim D., Collins M., Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene. 7:1992;27-32.
38. +-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells. Oncogene. 17:1998;1673-1680.
39. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
40. Schapiro F., Sparkowski J., Adduci A., Suprynowicz F., Schlegel R., Grinstein S. Golgi alkalinization by the papillomavirus E5 oncoprotein. J. Cell Biol. 148:2000;305-315.
41. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
42. Schiestl R. H., Gietz R. D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16:1989;339-346.
43. Schiller J. T., Vass W. C., Vousden K. H., Lowy D. R. E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J. Virol. 57:1986;1-6.
44. Schlegel R., Wade-Glass M., Rabson M. S., Yang Y. C. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science. 233:1986;464-467.
45. Sherman F., Fink G. R., Lawrence C. W. Methods in Yeast Genetics. 1979;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
46. Sparkowski J., Mense M., Anders J., Schlegel R. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J. Virol. 70:1996;2420-2430.
47. Straight S. W., Herman B., McCance D. J. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69:1995;3185-3192.
48. Straight S. W., Hinkle P. M., Jewers R. J., McCance D. J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and affects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:1993;4521-4532.
49. Supek F., Supekova L., Beltran C., Nelson H., Nelson N. Structure, function, and mutational analysis of V-ATPases. Ann. N. Y. Acad. Sci. 671:1992;284-292.
50. Ullman C. G., Haris P. I., Kell B., Cason J., Jewers R. J., Best J. M., Emery V. C., Perkins S. J. Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16. Biochem. Soc. Trans. 22:1994.
51. Valle G. F., Banks L. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J. Gen. Virol. 76:1995;1239-1245.
52. Weisman L. S., Bacallao R., Wickner W. Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle. J. Cell Biol. 105:1987;1539-1547.
53. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
54. Yamashiro C. T., Kane P. M., Wolczyk D. F., Preston R. A., Stevens T. H. Role of vacuolar acidification in protein sorting and zymogen activation: A genetic analysis of the yeast vacuolar proton-translocating ATPase. Mol. Cell. Biol. 10:1990;3737-3749.
55. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. zur Hausen H. Human Pathogenic Papillomaviruses. 1994;131-156 Springer-Verlag, Heidelberg.